文献速递组学、生物样本库与精准医学流行病学与生物统计基础与转化研究

纵向稀疏单组学因子分析用于阿尔茨海默病高维血液生物标志物研究

Longitudinal Sparse Single-Omics Factor Analysis for High-Dimensional Blood Biomarkers in Alzheimer's Disease.
PubMed 文献 · Stat Med · 2026-01-01

研究提出LS-SOFA框架,对ADNI中五种血液组学数据进行纵向稀疏因子建模,并用生存模型检验各视图与痴呆发病时间的关联。模拟显示其估计更准确、检验更稳定;应用发现血浆脂质组与血清代谢组(FIA和UPLC)经FDR校正后与痴呆风险显著相关。

要点

  • LS-SOFA可处理高维稀疏纵向组学数据并控制计算成本。
  • 血浆脂质组和血清代谢组与MCI进展为痴呆的风险显著相关。
  • 肠道微生物代谢组仅呈名义关联证据。

核心结论

  • LS-SOFA能识别与MCI患者痴呆发病时间相关的血液组学视图,血浆脂质组和血清代谢组(FIA和UPLC)经FDR校正后显著关联。

研究设计与样本

  • 方法学研究:提出LS-SOFA框架,用视图特异性潜因子和特征权重矩阵建模各組学视图,以FPCA捕捉时间动态,FPC得分纳入生存模型检验关联。
  • 应用于ADNI研究的五种血液组学视图,并与竞争方法进行模拟比较。

主要发现

  • 模拟中LS-SOFA的纵向估计精度更高、假设检验更稳定。
  • ADNI应用中,血浆脂质组和血清代谢组(FIA和UPLC)经FDR校正后与痴呆风险显著相关。
  • 血清肠道微生物代谢组仅呈名义关联证据。
  • 各视图顶部特征揭示具生物学可解释性的代谢通路,可能作为AD进展的血液生物标志物。

临床怎么用

  • 可将LS-SOFA用于纵向血液组学数据,筛选与痴呆发病时间相关的组学视图和特征。
  • 血浆脂质组和血清代谢组(FIA和UPLC)可作为MCI患者痴呆风险分层的候选血液标志物来源。

局限性

  • 肠道微生物代谢组的关联仅为名义证据,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alzheimer's disease (AD) is a progressive neurodegenerative disorder whose molecular mechanisms involve multiple biological pathways. Longitudinal blood-based omics data, such as lipidomics and metabolomics profiles, offer promising noninvasive biomarkers for early detection and prognosis, yet they are high-dimensional, sparse, and exhibit complex temporal and cross-feature correlations. The primary goal of this study is to identify which omics data types are most strongly associated with time to dementia onset in patients with mild cognitive impairment (MCI) at baseline. To address this, we propose a longitudinal sparse single-omics factor analysis (LS-SOFA) framework that models each omics view through view-specific latent factors and feature-weight matrices, with temporal dynamics captured by functional principal component analysis (FPCA). The resulting functional principal component (FPC) scores are incorporated into a survival model to test whether each omics view is associated with time to dementia onset. An efficient covariance-based estimation algorithm substantially reduces computational and memory cost, enabling large-scale application in the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. In simulations, LS-SOFA achieves higher longitudinal estimation accuracy and more stable hypothesis testing than competing methods. Applied to five blood-based omics views from ADNI, LS-SOFA identified plasma lipidomics and serum metabolomics from FIA and UPLC as significantly associated with dementia risk after FDR adjustment, with nominal evidence of association for gut microbial metabolomics from serum. The top features within each omics view reveal biologically interpretable metabolic pathways that may serve as blood-based biomarkers for AD progression.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Zou H, Kaddurah-Daouk R, Luo S, et al. Longitudinal Sparse Single-Omics Factor Analysis for High-Dimensional Blood Biomarkers in Alzheimer's Disease. Stat Med. 2026. PMID: 42136096. doi:10.1002/sim.70601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。